Nevada 2025 Regular Session

Nevada Assembly Bill AB282

Introduced
2/24/25  
Refer
2/24/25  
Report Pass
4/21/25  
Engrossed
4/28/25  
Refer
4/29/25  
Report Pass
5/19/25  
Refer
5/21/25  
Report Pass
6/1/25  
Enrolled
6/5/25  
Vetoed
6/11/25  

Caption

Revises provisions relating to billing for health care. (BDR 40-785)

Impact

The implementation of AB282 would bring significant changes to healthcare billing practices within the state. By formalizing a process for patients to report and resolve billing discrepancies, the bill empowers consumers and enhances accountability among healthcare providers. Additionally, the introduction of administrative fines—up to $5,000 for non-compliance in refund issuance—serves as a deterrent against poor billing practices. These measures can potentially lead to a more transparent and fair billing environment in healthcare, fostering trust between patients and providers.

Summary

Assembly Bill No. 282, spearheaded by Assemblymember Orentlicher, focuses on enhancing consumer protections regarding healthcare billing. The bill mandates that medical facilities and billing entities must address overcharge complaints from patients. Upon receiving notice of an alleged overcharge, these entities are required to conduct an investigation and respond to the patient within 30 days. Notably, the bill stipulates that if an overpayment is confirmed, the entity must issue a refund to the patient within 60 days. This practice aims to safeguard patients against erroneous billing and ensure timely reimbursement where applicable.

Contention

While the bill has garnered support for its potential to improve patient rights and billing accuracy, there may be concerns raised by providers regarding the compliance demands it imposes. Some healthcare organizations may perceive the new regulations as burdensome, particularly the requirement to investigate claims within a short timeframe. There might also be apprehensions about the financial implications of potential fines for non-compliance. However, supporters argue that failing to address these issues leads to unjustified financial burden on patients and firms, making the bill a necessary reform in consumer protection.

Companion Bills

No companion bills found.

Previously Filed As

NV SB385

Revises provisions relating to health care. (BDR 40-375)

NV SB348

Revises provisions relating to health facilities. (BDR 40-51)

NV AB383

Revises provisions relating to health care. (BDR 40-116)

NV AB7

Revises provisions relating to electronic health records. (BDR 40-381)

NV SB146

Revises provisions relating to health care. (BDR 40-462)

NV AB234

Makes revisions relating to health care. (BDR 40-61)

NV SB391A

Revises provisions relating to dentistry. (BDR 40-455)

NV SB283

Revises certain provisions relating to health care . (BDR 54-555)

NV SB419

Makes revisions relating to public health. (BDR 40-748)

NV AB6

Revises provisions relating to the cost of health care. (BDR 40-380)

Similar Bills

DE SB296

An Act To Amend Title 6 Of The Delaware Code Relating To Antitrust.

LA HB595

Provides relative to the towing industry (OR INCREASE SG EX See Note)

CT HB05252

An Act Concerning Revisions To The Connecticut Antitrust Act And Discovery Conducted By The Attorney General In Whistle-blower And False Claims Actions.

OH HB182

Regards precomputed consumer installment loans

NY S08319

Enacts the "New York city small business rent stabilization act" instituting a commercial rent control system in the city of New York; creates the commercial rent guidelines board.

NY A05568

Enacts the "New York city small business rent stabilization act" instituting a commercial rent control system in the city of New York; creates the commercial rent guidelines board.

PA HB2012

Providing for cause of action for antitrust conduct, for indirect purchaser recovery under State antitrust laws and for premerger notice of health care mergers and transactions; and imposing penalties.

NJ S901

Updates notice requirements for actions alleging consumer fraud violations and adds indirect purchasers as parties who can receive damages for antitrust violations.